Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Advita Life Science, Bioarctic, Brii, Can-Fite, Chimeric, Corat, Eisai, I-Mab, Kancera, Kintor, Lipidor, Medincell, Obi, Ocugen, Oncotelic, Organicell Regenerative Medicine, Relief, SAB, Shanghai Junshi, Sorrento, Trevena, Valneva, VBI Vaccines, Verona, Vir.